Symptoms related to abnormal gastrointestinal function can occur from the moment food is swallowed to the time faeces are expelled from the body (Fig. 1) . Dysphagia, heartburn, bloating, abdominal pain and changes to bowel habits are very common in the general population 1 . A survey published in 2014 reported that the prevalence of GERD, dyspepsia and IBS varies between 5% and 15% in European countries 1 . The symptoms caused by these disorders are among the most frequent reasons for seeking medical attention from general physicians and are also common grounds for referral to specialist gastroenterologists 1 . These functional gastrointestinal diseases (FGIDs) affect activities of daily living, reduce work-related productivity and incur high direct and indirect health-care costs 2 . Indeed, although life expectancy is normal in patients with FGID 3 , the burden of disease in terms of quality of life can be compared with that of cardiac failure or advanced malignancy 4 . The success of modern, scientific medicine is based on identifying and treating the pathophysiological basis of so-called organic diseases (for example neoplasia, inflammation, achalasia and other major motility disorders). However, this approach has not been realized in the field of FGIDs. The Rome IV criteria published in 2016 classify these conditions on the basis of the presence of specific digestive symptoms for at least 3 months of the 6 months before diagnosis in the absence of other diseases on appropriate investigation 5 . This process can include endoscopy (with biopsies), medical imaging and laboratory tests to rule out cancer and conditions such as peptic ulceration, coeliac disease and colitis. For patients with mild symptoms, negative tests provide reassurance and simple, symptomatic management might be all that is required (for example, acid suppression and/or stool regulation). However, for those with severe symptoms that persist on therapy, ruling out life-threatening disease is not sufficient, and referral for specialist investigations of gastrointestinal motility and function is often indicated.
The aim of physiological investigations is to explain the cause of digestive symptoms and establish a diagnosis that can guide rational and effective treatment. Until Dysphagia Difficulty or discomfort in swallowing as a symptom of disease.
Achalasia
A condition in which the lower oesophageal sphincter muscle fails to relax, preventing food from passing from the oesophagus into the stomach. 8 and Michael Camilleri 9 
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Abstract | Symptoms related to abnormal gastrointestinal motility and function are common. Oropharyngeal and oesophageal dysphagia, heartburn, bloating, abdominal pain and alterations in bowel habits are among the most frequent reasons for seeking medical attention from internists or general practitioners and are also common reasons for referral to gastroenterologists and colorectal surgeons. However, the nonspecific nature of gastrointestinal symptoms, the absence of a definitive diagnosis on routine investigations (such as endoscopy , radiology or blood tests) and the lack of specific treatments make disease management challenging. Advances in technology have driven progress in the understanding of many of these conditions. This Review serves as an introduction to a series of Consensus Statements on the clinical measurements of gastrointestinal motility , function and sensitivity. A structured, evidence-based approach to the initial assessment and empirical treatment of patients presenting with gastrointestinal symptoms is discussed, followed by an outline of the contribution of modern physiological measurement on the management of patients in whom the cause of symptoms has not been identified with other tests. Discussions include the indications for and utility of high-resolution manometry , ambulatory pH-impedance monitoring, gastric emptying studies, breath tests and investigations of anorectal structure and function in day-to-day practice and clinical management.
*e-mail: dr.mark.fox@ gmail.com the introduction of high-resolution manometry (HRM) approximately 10 years ago, and even today for certain other investigations, it could be argued that investigations of gastrointestinal motility and function rarely provided this information. As a result, only patients with clinical suspicion of major motility disorders such as achalasia, severe reflux disease or faecal incontinence under consideration for surgery were referred for tests. Even in this group, many diagnoses were subjective and based on the clinical presentation rather than the results of physiological measurement 6 . Technological advances have improved the reliability and clinical utility of these investigations. Neurogastroenterology and motility laboratories now provide measurements not only of motility but also of function in terms of the movement (and digestion) of ingested material within the gastrointestinal tract. This approach is important because symptoms do not usually occur unless abnormal motility disrupts function. The measurement of visceral sensitivity in clinical practice remains a challenge; however, the ability to associate gastrointestinal events (such as contractions, bolus retention, reflux or accelerated or delayed colonic transit) with symptoms provides some indication of how the patient responds to a stimulus. This association is important because both hypersensitivity and hyposensitivity are frequent causes of symptoms and disease in patients referred for investigation 7 . This paper provides an introduction to a series of expert consensus documents initiated by the International Working Group for Disorders of Gastrointestinal Motility and Function and published by Nature Reviews Gastroenterology & Hepatology. These Consensus Statements summarize the state of the art in clinical measurements of the pharyngeal swallowing, oesophageal motility 8 , GERD 9 , gastric and intestinal function 10 , and anorectal continence and defecation 11 . The lead authors of each article were invited to contribute to the current manuscript. Consensus was achieved through careful evaluation and discussion of available literature and expert agreement when recommendations lacked supporting evidence. All authors consented to the final version of the manuscript.
The first part of this Review provides a structured, evidence-based approach to the initial management of patients with symptoms related to disorders of gastrointestinal motility and function. The second part outlines the contribution of the neurogastroenterology and motility laboratory to the diagnosis and treatment of patients in whom no definitive cause of symptoms or disease has been identified on endoscopy, radiology and other appropriate investigations. In the latter section, unless otherwise stated, contents are based on the published consensus documents.
Initial management
The primary aim of the initial assessment of patients with gastrointestinal symptoms is to identify alarm features such as dysphagia, anaemia or weight loss that could indicate the presence of neoplasia, ulceration or inflammation in the digestive tract (Box 1). If present, then it is obligatory to perform endoscopy and/or imaging depending on the presenting complaint. Prospective trials and meta-analysis indicate that the presence of alarm features is associated with a 5-10% risk of life-threatening disease, compared with a 1-2% risk in patients without these markers 12, 13 . Conversely, if no symptoms or signs of life-threatening conditions are present, then invasive investigation is not necessarily required 14, 15 . Rather, the Rome criteria recommend that the diagnosis of FGIDs be based on clinical presentation and negative results on appropriate tests 5 (Box 2). Although no item in the clinical history of a patient is diagnostic, there are many features that help to differentiate patients with an organic disease and those with FGIDs (TABle 1) . One important consideration is that patients with a defined aetiology tend to have discrete symptoms that remain stable or progress over time, whereas those with a functional aetiology often complain of multiple and changeable symptoms (for example, dyspepsia, IBS and fibromyalgia) 16, 17 . Another factor is that patients seeking medical attention for functional gastrointestinal symptoms have an ~50% rate of psychiatric disease such as anxiety, depression or somatization, compared with the ~20% rate seen with 'organic' conditions (such as peptic ulceration or colitis) and the ~10% rate seen in the general population 18, 19 . Furthermore, the presence
Key points
• Symptoms have poor specificity for gastrointestinal diseases, and there is a marked overlap between 'organic disease' (including major motility disorders) and functional gastrointestinal disease, underlining the need for testing to guide treatment.
• New technology has driven progress, improved our understanding of gastrointestinal physiology and revolutionized the clinical measurement of gastrointestinal motility and function from oropharynx to anorectum.
• Adherence to validated methodology is essential for the assessment of gastrointestinal motility and function to provide meaningful results.
• Diagnoses based on valid, objective metrics (for example, Chicago Classification for oesophageal motility disorders, gastric emptying retention time and colonic transit times) are replacing subjective assessments from physiological studies.
• High-resolution manometry has improved the inter-observer agreement and accuracy of diagnoses in patients with disorders of oesophageal and anorectal motility and function.
• The importance of abnormal visceral sensitivity has been demonstrated in patients with functional gastrointestinal diseases.
High-resolution manometry (HRM). A diagnostic system that measures intraluminal pressure activity from the throat to the stomach using a series of closely spaced pressure sensors.
Visceral sensitivity
A term used to describe the intensity of sensation (for example, fullness or pain) induced by stimulation applied to the abdominal organs (viscera). Hyposensitivity indicates that stimulation induces less intense sensation than normal; hypersensitivity, indicates that stimulation induces more intense sensation than normal.
NATuRE REvIEWS | GAStrOEntErOlOGy & HEpAtOlOGy of psychosocial stressors (such as unemployment or bereavement) is associated with more frequent complaints of symptoms, more time off work and failure to respond to specific management 20 . Many experts ask patients to complete standardized questionnaires to ensure that clinically relevant psychopathologies in patients with FGIDs are recognized early in the diagnostic process.
After initial assessment, if abnormal gastrointestinal motility and function is considered the probable cause of symptoms, then this diagnosis should be communicated to the patient. Patients with symptoms and signs suggestive of aspiration or a major motility disorder, especially in association with impaired food intake and nutritional health, require early referral to a neurogastroenterology and motility laboratory. For the remainder of patients, a trial of empirical treatment is recommended before further investigation is considered. A general approach to the initial assessment and management of patients is presented in (Fig. 2) .
For oesophageal and dyspeptic symptoms, a short course of twice-daily proton-pump inhibitor (PPI) therapy is recommended 14, 15 . Meta-analyses show that acid suppression usually improves symptoms related to gastrooesophageal reflux and can also be effective in functional dyspepsia [21] [22] [23] . At the same time, a test and treat approach for Helicobacter pylori infection is appropriate, although the effect on symptoms is modest (number needed to treat was >10 in placebo-controlled trials) 23 . For intestinal and colorectal symptoms, first-line treatment includes antispasmodic agents (such as hyoscyamine), increased dietary fibre or artificial fibre supplements (for example, psyllium preparations) and other medications that regulate bowel frequency and consistency (such as polyethylene glycol for constipation and loperamide for diarrhoea) 24 . A trial of anti-emetic or prokinetic medications (for example, ondansetron, domperidone and stimulant laxatives) can also be considered. If initial therapy does not improve symptoms, then low-dose antidepressant therapy (such as amitriptyline, mirtazapine or citalopram) has been shown to be effective in a range of functional gastrointestinal symptoms, in particular, nausea and abdominal pain [25] [26] [27] . The benefit of these medications is thought to be related primarily to reduction in visceral hypersensitivity; however, some antidepressants also have effects on motility. For example, mirtazapine accelerates gastrointestinal transit in animal studies 28 and has been shown to have symptomatic benefits in functional dyspepsia and refractory gastroparesis in clinical trials 29, 30 . Similarly, amitriptyline slows colonic transit and inhibits rectal contractility in patients with faecal incontinence 31 . Non-pharmacological therapy is also of proven value and is preferred by many patients. This includes the involvement of dieticians to manage food intolerance 32 and to facilitate nutrition in patients with symptomatic gastroparesis through education on the use of small-particle diets 33 ; physiotherapists to treat symptoms related to muscle tension in the abdominal wall, diaphragm and pelvic floor (for example, bloating, rumination and constipation owing to evacuation disorders caused by pelvic floor dyssynergia) 34, 35 ; and therapists to support patients with a psychiatric comorbidity 27 . Many patients in primary care respond well to this simple, empirical management; however, an important minority report persistent symptoms during treatment or adverse effects of therapy. In these individuals, referral for investigations of gastrointestinal motility and function to assess the causes of symptoms is appropriate (TABle 2) . Others might insist on investigation before embarking on potentially costly and/or time-consuming management (for example, dietary therapy). Increasing evidence reviewed for the International Working Group for Disorders of Gastrointestinal Motility and Function indicates that the results of these tests can identify clinically relevant pathologies and guide rational management [8] [9] [10] [11] .
Disorders of swallowing
For oropharyngeal dysphagia and related symptoms (for example, coughing related to swallowing), the first investigation is a video fluoroscopic swallowing exam, which can visualize the structure and function of the oropharynx and document laryngeal penetration or overt aspiration 36 . An alternative approach favoured by ear, nose and throat specialists is fibreoptic endoscopic evaluation of swallowing, which can assess laryngopharyngeal motor and sensory function 37 . However, if imaging and endoscopy do not deliver a definitive diagnosis, then HRM, ideally combined with impedance, could identify the cause of symptoms and determine the risk of aspiration [38] [39] [40] . In the future, brain imaging and other neurophysiological tools might enable characterization of the sensorimotor integration processes involved in deglutition 41 . It is hoped that an analysis of these complex data will identify the mechanism of oropharyngeal dysphagia and direct effective management.
Important progress has been made in the clinical investigation of oesophageal dysphagia. Advances in catheter technology now provide a near continuous, high-resolution representation of pressure activity from the mouth to the stomach 6 . Moreover, the combination of manometry with intraluminal impedance enables simultaneous assessment of motility and bolus movement through the oesophagus 6, 42 . A key insight from these studies is that dysphagia and other symptoms are rarely caused by abnormal motility unless it is accompanied by impaired function.
With the introduction of HRM technology, it was necessary to develop a new classification system to diagnose oesophageal motility disorders. The Chicago Classification, now in its third iteration 43 , is based on objective measurements acquired during a series of ten 'single water swallows' . The metrics used in this analy sis have been validated in physiological studies of oesophageal function 43 . The system is hierarchical, with oesophagogastric junction (EGJ) dysfunction considered first because failure of the EGJ to relax and/or open in achalasia and outflow obstruction has a greater effect on bolus transport than abnormalities in peristalsis such as spasm or aperistalsis 44 . In addition, the Chicago Classification makes a clear distinction between major motility disorders that are never observed in healthy individuals and are always associated with a clinical disease and minor abnormalities that are outside the normal range but can be observed in patients without dysphagia and, occasionally, in healthy individuals. In the former group, with conditions such as achalasia or spasm, there is a clear rationale for treatment directed at correcting the pathology 43 . In the latter group with minor abnormalities the association of minor motility disorders with patient symptoms is less certain, and other factors could also be involved (for example, acid reflux or visceral hypersensitivity) 45, 46 . Compared with conventional manometry with fewer than eight sensors, the assessment of oesophageal motility using HRM has been shown to have a higher inter-observer agreement and to increase diagnostic yield and accuracy for motility disorders [47] [48] [49] . The findings also influence clinical management. On the basis of HRM measurements, three subtypes of achalasia are defined on the basis of the absence or presence of pan-oesophageal pressurization (type I and type II, respectively) and spasm (type III) 50 . This classification is used to guide treatment decisions and predicts the outcome of endoscopic and surgical management 50, 51 . The effect of this technology on the diagnosis and management of achalasia is detailed in a Consensus Statement published in 2017 (ReF. One key weakness of current HRM studies is that, in the absence of major dysmotility, the results do not explain the cause of symptoms because few patients experience dysphagia on swallowing small volumes of water 52 . Studies have applied HRM, ideally with impedance, to assess oesophageal function during normal drinking and eating [52] [53] [54] . This approach can reveal major oesophageal motility disorders not detected by standard tests 54 ( Fig. 3) . For example, a study published in 2015 showed that including a test meal increases the diagnostic yield of HRM for clinically relevant outlet obstruction in patients with dysphagia after fundoplication. The majority of those with outlet obstruction responded to balloon dilatation of the fundoplication wrap 55 . Additionally, the combination of HRM with a test meal can clarify the severity of minor motility disorders and, by associating oesophageal dysfunction with symptoms, provide some insight into the role of visceral sensitivity in patients with functional dysphagia 52, 56 . Extending HRM observations after the meal can also be of interest in patients with therapy-resistant reflux and other postprandial symptoms. These observations can differentiate typical reflux events from behavioural disorders such as rumination syndrome and supragastric belching 34 . GERD GERD is common worldwide, with at least one in ten individuals of the general population experiencing heartburn or acid regurgitation 2-3 times per week 1 . In the absence of alarm symptoms, the initial clinical diagnosis of GERD is based on the symptomatic presentation and response to empiric antisecretory therapy 57 . Further investigations are indicated in patients with persistent symptoms on treatment with high-dose acid suppression (PPIs twice daily), those with alarm symptoms and those under consideration for anti-reflux surgery 58, 59 . Endoscopy is performed to detect mucosal disease in the oesophagus and exclude other pathologies such as peptic ulcer or cancer. Erosive reflux disease or Barrett oesophagus is present in ~30% of patients referred for investigation off PPI treatment, but these are present in less than one in ten in patients on acid suppressants 60 . Non-erosive (or endoscopy negative)
Intraluminal impedance
A catheter-based method to detect the presence of food, fluid or gas within the lumen of the oesophagus. Measuring impedance at multiple sites (multichannel) allows for determination of the direction of movement of oesophageal contents. Combined with pH measurement, this technique is considered the gold standard for detection of acid and nonacid reflux events.
Oesophagogastric junction
(egJ). A complex valve composed of an intrinsic, smooth muscle element (lower oesophageal sphincter and gastric cardia) and an extrinsic, striated muscle element (diaphragm).
Supragastric belching
A condition, thought to be a learned habit, in which air is repetitively sucked into the oesophagus and then immediately expelled (belched).
Box 2 | Initial investigations in functional gastrointestinal disease
• Full blood count, renal, liver and thyroid function tests, calcium levels, and coeliac serology testing, including anti-transglutaminase antibody • Serology or a urea breath test for Helicobacter pylori infection (acid suppression medications should be stopped for ≥1 week before test) • Stool tests including faecal calprotectin levels to screen for colonic pathology (colitis and/or large polyps) and faecal occult blood can also be considered; imaging preferred to faecal elastase to detect pancreatic pathology • Gastrointestinal endoscopy in the presence of alarm features or in patients with persistent symptoms despite initial medical management; even in the absence of macroscopic disease, appropriate biopsy samples taken to exclude eosinophilic oesophagitis (dysphagia), H. pylori infection (dyspepsia), coeliac disease or sprue (dyspepsia and/or diarrhoea) and microscopic colitis (diarrhoea) • Abdominal ultrasonography to exclude gall bladder and other abdominal pathologies is routine in many European countries; however, diagnostic yield is low unless clinical suspicion of specific disorders is present 140, 141 • CT should not be routine, especially in young women, to avoid unnecessary exposure to radiation reflux disease is diagnosed in patients with symptoms but without mucosal erosions or metaplasia on endoscopic examination 57, 61 . The sensitivity and specificity of a symptomatic diagnosis, including empiric response to PPI therapy, are not always consistent with the results of objective measurements of oesophageal reflux 62 . In a large clinical study published in 2010, heartburn and acid regurgitation were present in only 49% of patients with pathological levels of acid exposure during 48 h wireless (Bravo, Medtronic, USA) pH studies 63 , conversely, 23% of patients with typical reflux symptoms had normal levels of acid exposure 63 . Physiological studies are also performed in patients with atypical symptoms that can be triggered by gastrooesophageal or supra-oesophageal reflux such as epigastric pain, chronic cough or pharyngeal symptoms (for example, hoarseness, sore throat or globus sensation); however, in this patient group, only ~25% of tests are positive 64 . Overall, the weak association between patient symptoms and the presence of pathological reflux highlights the importance of objective measurements to differentiate patients with GERD-related symptoms from those with a functional disease (for example, reflux hypersensitivity) or symptoms unrelated to reflux.
Oesophageal motility testing with HRM can identify a hypotensive EGJ and/or morphological abnormalities at the EGJ (hiatus hernia), both of which contribute to the pathophysiology of reflux [65] [66] [67] . However, transient lower oesophageal sphincter relaxation, the most common mechanism of reflux, is not evaluated on routine motility testing despite validation of HRM criteria for the identification of these events 68 . Oesophageal clearance of refluxate is optimal with normal oesophageal peristalsis, whereas ineffective oesophageal motility (fragmented peristalsis and weak peristalsis) or absent contractility can contribute to prolonged residence times of oesophageal refluxate and lead to increased oesophageal acid exposure 69, 70 . Provocative (or 'adjunctive') testing during HRM can be used to identify patients with ineffective motility with sufficient 'contractile reserve' who can respond when challenged with repetitive swallowing (multiple rapid swallows and/or rapid drink challenge) or a solid test meal 54, [71] [72] [73] [74] . Demonstration of the presence of an effective 'contraction reserve' is particularly important if anti-reflux surgery is being considered 71, 72 . Characterization of EGJ integrity and oesophageal body motor function with contraction reserve is an essential element of motility evaluation in GERD.
Guidelines recommend that the diagnosis of GERD be based either on ambulatory pH studies or, ideally, combined pH and multiple intraluminal impedance studies 58, 59 . The sensitivity of the investigation is optimal if PPI medications are stopped at least 7 days before the study. The advantage of the combined system is that impedance can detect all reflux events, irrespective of acidic content, and also indicates the proximal extent of reflux events. In patients who fail to respond to PPI therapy, weakly acidic reflux that extends into the proximal oesophagus or pharynx is an important cause of both typical symptoms (especially regurgitation) and atypical symptoms (especially cough) 64, 75 . Additionally, impedance measurements can detect the movement of air through the oesophagus and document behavioural conditions such as aerophagia and supragastric belching that can be the cause of symptoms in patients with otherwise negative results in ambulatory reflux studies 76 . Limitations of these ambulatory studies include catheter intolerance in ~10% of patients and a similar proportion in whom catheter-related nasopharyngeal discomfort disturbs normal eating, work or sleep, leading to false negative results 77, 78 . In such situations, wireless pH monitoring (Bravo system, Medtronic, USA) provides a method that is well tolerated by most patients 77 .
A further advantage of this wireless system is that this Patients with 'organic disease' are those with a diagnosis based on a unique pathology on histology or clinical measurement (for example, neoplasia, inflammation, major motility disorders or severe GERD), and patients with functional gastrointestinal diseases are those with a diagnosis based on characteristic symptoms supported by the absence of a definitive pathology on investigations (for example, dyspepsia or IBS).
Contraction reserve
A term used to describe the increase in oesophageal contractility seen in response to physiological challenge (for example, multiple rapid swallows or reflux).
Aerophagia
A condition, thought to be a learned habit, in which excessive air swallowing leads to gastric distension and abdominal bloating.
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catheter-free approach enables prolonged (up to 96 h) monitoring, which improves the ability to demonstrate an association between acid reflux and symptoms 79 . Wireless pH-monitoring studies are reported to identify GERD in up to one in three patients with previously negative catheter-based tests 77 . As detailed in an accompanying Consensus Statement by the GERD working group 9 , the classification of ambulatory reflux studies is based on the presence or absence of pathological acid exposure and/or an increased number of reflux events (acid and otherwise) detected by impedance measurements and a close temporal association between reflux events and patient symptoms 80 . To compensate for high day-to-day variability in these metrics, the Lyon Consensus from 2018 recommends that GERD can be diagnosed not only in patients with severe acid exposure ( >6% pH <4 over 24 h) but also in patients with borderline acid exposure (4-6% pH <4 over 24 h) if supported by other HRM data (for example, an unstable EGJ (hiatus hernia) or ineffective oesophageal motility) 80 . Reflux hypersensitivity is diagnosed in patients with normal acid exposure and/or numbers of reflux events but a positive reflux-symptom association. The diagnosis of functional heartburn is applied in the remainder of patients with reflux symptoms but without objective evidence of oesophageal disease. This classification system is clinically relevant in that it has been shown that patients with objective evidence of GERD on physiological measurement have markedly better responses to medical or surgical therapy (typically 70-90%) than patients with typical symptoms in whom acid exposure is normal and the association of reflux events with symptoms is weak or absent (typically 30%) [81] [82] [83] [84] . In the latter group, treatment with antidepressants with the aim of reducing visceral sensitivity is recommended. A systematic review of this approach in patients with functional oesophageal syndromes reported improvement in 23-61% of patients taking antidepressants compared with ongoing PPI therapy alone 85 .
Gastric emptying and digestion disorders
Abnormal gastrointestinal motility and sensitivity have been documented in a range of conditions such as gastroparesis, functional dyspepsia and IBS 86 . An accompanying Consensus Statement explores a range of technologies used to assess gastric and intestinal function 10 . Measurement of delayed or accelerated gastric emptying and small intestinal transit times by gastrointestinal scintigraphy, 13 C-urea breath tests or the wireless motility capsule (SmartPill, Medtronic, USA) provides diagnostic information in cases of excessively rapid (dumping) or delayed gastric emptying (gastroparesis) 87, 88 . To obtain reliable results, it is essential that a validated methodology is applied. For example, solid meal tests might be more sensitive to gastroparesis, whereas liquid meal tests might better detect acceleration of early gastric emptying associated with gastric dumping. The low-fat 'eggbeater' meal is the best-established test meal used with gastric scintigraphy 89, 90 . Using this method, delayed gastric emptying is documented in ~40% of patients with functional dyspepsia and in up to 75% of patients with chronic, unexplained nausea and
Gastrointestinal scintigraphy
A test in which a radiolabelled substance (for example, an 'eggbeater' meal) is ingested to provide a non-invasive and quantitative measure of gastric emptying and/or orocaecal transit.
Empirical management
• Consider early referral for physiological measurement (e.g. dysphagia)
• Upper gastrointestinal system: consider acid or reflux suppression, anti-emetics or prokinetics • Lower gastrointestinal system: consider stool-bulking agents, laxatives, imodium or pelvic floor training vomiting [91] [92] [93] . An association between dyspeptic symptoms and gastric emptying has been observed in some, but not all, studies [93] [94] [95] [96] [97] [98] [99] . Severely delayed emptying (gastroparesis or gastric failure) is associated with postprandial vomiting, weight loss, poor health status and poor outcome of therapy 29, 93, 100 . However, the results do not necessarily predict clinical responses to metoclopramide or other prokinetic and anti-emetic medications 101, 102 . More sophisticated investigations assess gastric accommodation, contractility and sensitivity (for example, gastric barostat studies, single-photon emission CT and MRI). These measurements correlate more closely than gastric emptying with patient symptoms (for example, postprandial fullness is associated with impaired accommodation and visceral hypersensitivity); however, these tests are not widely available and are reviewed elsewhere 87, 103, 104 . Early experience with methods that use scintigraphy to document gastric filling (accommodation), contractility and emptying with concurrent assessment of patient symptoms show promise in early trials 105, 106 . Antroduodenojejunal (ADJ) manometry is used to exclude major gastric and intestinal motility disorders in patients with severe, therapy-resistant constipation (a contraindication for colectomy) and also in patients with suspected intestinal obstruction but with no definitive diagnosis on radiology 107 . ADJ manometry may also differentiate between myopathic and neuropathic pathology 87 . Similarly, colonic manometry provides insight into the causes of lower gastrointestinal symptoms and disease 108 . Unfortunately, these studies are difficult and time consuming to perform (ideally 24 h) and analyse. For this reason, most clinicians apply noninvasive tests to assess intestinal and colonic transit time using scintigraphy, wireless motility capsules or radioopaque markers (whole-gut transit time only). Objective evidence of slow transit indicates the need for more intensive laxative or prokinetic therapy. Conversely, if these investigations show normal intestinal and colonic transit, then the diagnosis is most likely to be a FGID such as IBS 109 . However, there is a marked and unclear overlap between patients with intestinal dysmotility and patients with FGIDs in whom altered gastrointestinal motility is only one among several pathological mechanisms responsible for symptoms 86, 87 . One potential advantage of the wireless motility capsule is that it collects information about multiple parameters including gastric, small bowel and colonic transit (that is, function), intraluminal pressure (that is, motility) and pH (a surrogate for bacterial fermentation in the large bowel) 110, 111 . This investigation can be performed in office-based practice; however, as yet, it is uncertain whether the information acquired can replace scintigraphy or manometry or influence management.
Gastric accommodation
A term used to describe the relaxation of the stomach (reduction in gastric tone and increase in compliance) that follows ingestion of a meal. Se-HCAT, selenium homocholic acid taurine; FODMAP, fermentable oligosaccharides, disaccharides, monosaccharides and polyols; HRM, high-resolution manometry. a Alarm Symptom; endoscopy or imaging should be performed before physiological investigation. b Cautionary symptom; ischaemic heart disease must be excluded before physiological investigation.
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One type of investigation not covered in the consensus document is the hydrogen breath test. These tests document malabsorption of lactose, fructose and other carbohydrates that are present in the diet and can be a cause of bloating, diarrhoea and other symptoms on the basis of the principle that hydrogen is not produced by human metabolism but is a product of bacterial fermentation in the gastrointestinal tract 112, 113 . In healthy individuals, hydrogen is produced when nutrients are not fully absorbed in the small bowel but are fermented in the colon. Rapid diffusion into the bloodstream and then the lungs allows gas produced in the colon to be detected in the breath within 3 min of the substrate coming into contact with bacteria 114 . If the increase in exhaled hydrogen is associated with the onset of typical abdominal symptoms, then the presence of food (for example, lactose) intolerance is confirmed. The risk of intolerance increases not only with the dose and the amount of gas produced by the bacteria but also with patient factors 115, 116 . For example, many patients with lactase deficiency and IBS experience bloating, pain and diarrhoea after ingestion of 20 g lactose (500 ml milk), whereas the majority of healthy individu als with lactase deficiency tolerate this amount of lactose without difficulty 115 . Hydrogen breath tests using glucose or lactulose as the substrate are also used to detect small intestinal bacterial overgrowth (SIBO); however, studies have highlighted limitations of these investigations 117, 118 . False negative tests are common owing to the presence of bacteria that do not produce hydrogen, and the addition of methane measurements improves sensitivity only slightly 113 . False positives are common owing to high variability in gastrointestinal function and, in the case of lactulose, effects of the substrate on intestinal transit time 119 . As a result, the clinical relevance of these findings is debated. Some of these limitations can be addressed by combining the lactulose hydrogen breath test with an independent assessment of orocaecal transit time by scintigraphy. This approach can differentiate between an early increase in breath hydrogen due to SIBO and rapid orocaecal transit time, both of which are thought to be causes of symptoms in patients with IBS 119 .
Disorders of anorectal function
The rectum and anal sphincter act together with the pelvic floor musculature to maintain faecal continence and control defecation 120 . Problems with anorectal function are common in the general community, especially in women who have had children, individuals with previous anorectal surgery and elderly individuals 121, 122 ; however, many patients find it embarrassing to describe these problems 123 . In particular, stool incontinence might not be revealed unless specific questions are asked. Standard questionnaires and the Bristol Stool Score can be very helpful for this purpose 123, 124 . As detailed in the accompanying Consensus Statement by the anorectal working group 11 , physiological investigations are indicated in patients with faecal incontinence, chronic constipation and difficulties in passing stool (so-called evacuation disorders) that do not respond to empirical treatment with medications that regulate stool consistency and pelvic floor training. It is important to appreciate that these disorders frequently coexist, which will affect management 125 . Clinical investigations of anorectal function include endoanal ultrasonography, manometry, measurements of rectal function and balloon expulsion. Additionally, defecography can image the structure and function of the pelvic floor at rest and during simulated defecation 126 . Although less well established than oesophageal HRM, anorectal HRM has been shown to document the function of the internal and external anal sphincter in more detail than conventional manometry and with a high degree of inter-observer agreement 127, 128 . In patients with continence problems, this assessment is combined with endoanal ultrasonography to image the structure of the anal sphincter (Fig. 4) . Measurements of rectal function can also be obtained during the same investigation, which is important because 20-40% of patients with faecal incontinence have normal anal sphincter function but either a small, non-compliant rectum or abnormal rectal sensitivity, and both rectal hyposensitivity and rectal hypersensitivity impair the ability to maintain faecal continence 120, 129, 130 . Together, these findings provide important insight into the causes of passive, urge and combined incontinence and faecal seepage. The results of these tests can direct specific management. For example, specialist biofeedback therapy is often effective for individuals with an intact sphincter that are unable to maintain squeeze pressure and also for those with urgency related to visceral hypersensitivity 131, 132 . By contrast, this form of training is less useful if symptoms are related to a pathology that cannot be improved by training (for example, a weak internal sphincter or grossly impaired rectal sensation 132 ). Surgical repair of the anal sphincter is usually reserved for patients with a weak squeeze pressure related to a large tear in the external sphincter. In others, application of sacral nerve stimulation is often effective 133 , with 71% of prospectively registered patients reporting ongoing improvement in faecal continence during follow-up and full continence achieved in 50% at a median of 7 years after implantation 134 .
In patients with chronic constipation or an evacuation disorder, the balloon expulsion test documents the ability of a patient to defecate a small, water-filled balloon from the rectum. If this expulsion is not achieved within a set time limit, then this is a marker of impaired evacuation that might be secondary to structural or functional abnormalities of the pelvic floor or anal sphincter 135 . Qualitative assessment of anorectal function by HRM can detect abnormal anorectal pressure activity and function in patients with dyssynergic defecation (for example, paradoxical contraction of the anal sphincter or inadequate push effort), with a high level of agreement with the results of magnetic resonance defecography 136 . However, as yet, valid quantitative measurements of anorectal pressure activity during defecation have not been established 137 . Defecography is particularly useful in detecting structural conditions that impair the passage of stool 136 . The results of manometry and imaging have direct effects on clinical management. If outlet obstruction is related to dyssynergic defecation, then biofeedback therapy is effective in up to 80% of patients, compared with 20% of patients treated with laxatives alone 138 , There is a rapid increase in pressure during voluntary squeeze contraction of the external sphincter. Note that the external sphincter extends below the internal sphincter, and this facilitates return of any stool in the anal canal to the rectum. The structure and function of the anal sphincter is disrupted in a patient with faecal incontinence following an obstetric injury (right). There is an acute tear in the external sphincter (indicated by white lines at the 12'o-clock and 2'o-clock positions). This tear is associated with failure to increase pressure during voluntary 'squeeze', which can be seen in the corresponding manometry image (top right). Continence function was restored following surgical sphincter repair.
Healthy volunteer

Biofeedback therapy
A specialist form of physiotherapy used to treat constipation and faecal incontinence in which sensors record muscle activity (for example, of the abdominal wall and anal sphincter) and give feedback to the patient to improve technique.
www.nature.com/nrgastro whereas in those with excessive pelvic floor descent, a large retaining rectocele with obstructive intussusception or prolapse, surgery is often required to restore functional anatomy. In patients in whom no pathology is identified, a colonic transit test using the Sitzmarks test, scintigraphy or a wireless motility capsule can be very helpful to confirm slow-transit constipation 86 . If transit is slow, then more intensive laxative or prokinetic therapy is required. Conversely, if this test shows normal transit, then the likely diagnosis is IBS or a related FGID with altered awareness of gastrointestinal function 109 . In such patients, treatments should be targeted towards improving visceral hypersensitivity or addressing psychosocial stressors, including a past history of abuse.
Conclusions
Symptoms related to abnormal gastrointestinal motility and function are very common; however, the nonspecific presentation, the absence of definitive diagnosis on endoscopy and other tests, the coexistence of psychosocial issues and the lack of specific treatments make the management of FGIDs challenging. The initial assessment must rule out life-threatening disease and select patients either for further investigation or a trial empirical, symptomatic management. In the past, the role of physiological investigations was limited; however, advances in technology and methods can now provide more meaningful assessment of gastrointestinal motility and function. Accurate and objective measurements enable definitive diagnoses that can have a direct effect on treatment decisions in clinical practice. However, even when no specific treatment can be offered on the basis of the results of these tests, a clear explanation of the causes of symptoms can be therapeutic in itself. Well-informed patients are more satisfied, cope with their condition better and seek medical attention less frequently than those that have not been fully informed 139 . Looking ahead (Box 3), new insights from basic and clinical science are needed to better understand the pathological basis of disorders of gastrointestinal motility and function. At the same time, there is a need for novel investigations and methods that identify not only abnormal motility but also abnormal sensitivity. Advances on all of these fronts are required to determine which patients with specific phenotypes of neurogastroenterology and motility diseases respond to specific treatments.
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Box 3 | Open research questions
• The clinical utility of numerical data over pattern recognition in certain tests (for example, antral motility index in gastroparesis, balloon expulsion and rectoanal pressure gradient testing in evacuation disorders) requires further study.
• Clinical investigations to explain the causes of symptoms in patients with functional gastrointestinal disease might require assessment of gastrointestinal structure, motility and sensation, which generally requires more than one modality of measurement.
• Current tests of gastrointestinal sensation require validation; new technologies and methodologies are under development to facilitate evaluation of visceral sensitivity in routine practice.
• outcome studies are required to assess indications, on the basis of motility measurements, for new therapies (for example, pyloric botulinum toxin injection and sacral nerve stimulation).
• Although the usefulness of some gastrointestinal function tests for diagnosis and decisions on management has been established, further studies on the cost-benefit ratio of physiological measurements in clinical practice are warranted.
Rectocele
A herniation (bulge) of the front (anterior) wall of the rectum into the back (posterior) wall of the vagina. it occurs when the fibrous tissue between the rectum and the vagina (rectovaginal septum) becomes thin and weak over time.
Intussusception
A process in which a segment of intestine, in this case rectum, telescopes (invaginates) into the lower rectum or anal canal, causing structural outlet obstruction and difficulty with defecation.
